UT-MD Anderson Cancer Center: MD Anderson Research Highlights for October 4, 2023
October 05, 2023
October 05, 2023
HOUSTON, Texas, Oct. 5 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following research highlight:
* * *
Featuring progress for peripheral neuropathy and chemobrain, a CAR T cell atlas, a therapeutic target for AML, and risk prediction tools for pancreatic and bone cancer
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and pre . . .
* * *
Featuring progress for peripheral neuropathy and chemobrain, a CAR T cell atlas, a therapeutic target for AML, and risk prediction tools for pancreatic and bone cancer
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and pre . . .